Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Pharmacoeconomics
|
September 14, 2010
Generating evidence for comparative effectiveness research using more pragmatic randomized controlled trials
C Daniel Mullins, Danielle Whicher, Emily S Reese, et al.
Pharmacotherapy
|
March 31, 2012
Cost-effectiveness of cytochrome P450 2C19 genotype screening for selection of antiplatelet therapy with clopidogrel or prasugrel
Emily S Reese, C Daniel Mullins, Amber L Beitelshees, et al.
Journal of Comparative Effectiveness Research
|
May 31, 2023
Advanced or metastatic biliary tract cancer in Japan: a study using the Japan Medical Data Center payer claims database
Ramzi Argoubi, Emily S Reese, Martina Furegato, et al.
Cancer Medicine
|
January 10, 2014
Clinical and demographic characteristics associated with the receipt of chemotherapy treatment among 7951 elderly metastatic colon cancer patients
Emily S Reese, Eberechukwu Onukwugha, Nader Hanna, et al.
Cancer Medicine
|
January 10, 2014
Does the type of first-line regimens influence the receipt of second-line chemotherapy treatment? An analysis of 3211 metastatic colon cancer patients
Zhiyuan Zheng, Nader Hanna, Eberechukwu Onukwugha, et al.
Journal of Comparative Effectiveness Research
|
November 19, 2013
The emerging relevance of heterogeneity of treatment effect in clinical care: a study using stage IV prostate cancer as a model
Nirupama D Mitikiri, Emily S Reese, Arif Hussain, et al.
Journal of the American College of Surgeons
|
September 11, 2015
Economic Impact of Alvimopan Considering Varying Definitions of Postoperative Ileus
Stephanie R Earnshaw, Teresa L Kauf, Cheryl McDade, et al.
Future Oncology (London, England)
|
April 7, 2022
Second-line treatments in advanced biliary tract cancer: systematic literature review of efficacy, effectiveness and safety
Zarmina S Khankhel, Sarah Goring, Sarah Bobiak, et al.
Molecular Genetics & Genomic Medicine
|
November 14, 2025
Living With Hypochondroplasia: A Qualitative Exploration of Children's and Caregivers' Experiences, Challenges, and Unmet Needs
Elisabeth M Oehrlein, Reni Pekala, Stacie Cavallaro, et al.
Cancer Medicine
|
October 20, 2022
Real-world outcomes among patients with advanced or metastatic biliary tract cancers initiating second-line treatment
David P Cosgrove, Emily S Reese, Nicole M Fulcher, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Pharmacoeconomics
|
September 14, 2010
Generating evidence for comparative effectiveness research using more pragmatic randomized controlled trials
C Daniel Mullins, Danielle Whicher, Emily S Reese, et al.
Pharmacotherapy
|
March 31, 2012
Cost-effectiveness of cytochrome P450 2C19 genotype screening for selection of antiplatelet therapy with clopidogrel or prasugrel
Emily S Reese, C Daniel Mullins, Amber L Beitelshees, et al.
Journal of Comparative Effectiveness Research
|
May 31, 2023
Advanced or metastatic biliary tract cancer in Japan: a study using the Japan Medical Data Center payer claims database
Ramzi Argoubi, Emily S Reese, Martina Furegato, et al.
Cancer Medicine
|
January 10, 2014
Clinical and demographic characteristics associated with the receipt of chemotherapy treatment among 7951 elderly metastatic colon cancer patients
Emily S Reese, Eberechukwu Onukwugha, Nader Hanna, et al.
Cancer Medicine
|
January 10, 2014
Does the type of first-line regimens influence the receipt of second-line chemotherapy treatment? An analysis of 3211 metastatic colon cancer patients
Zhiyuan Zheng, Nader Hanna, Eberechukwu Onukwugha, et al.
Journal of Comparative Effectiveness Research
|
November 19, 2013
The emerging relevance of heterogeneity of treatment effect in clinical care: a study using stage IV prostate cancer as a model
Nirupama D Mitikiri, Emily S Reese, Arif Hussain, et al.
Journal of the American College of Surgeons
|
September 11, 2015
Economic Impact of Alvimopan Considering Varying Definitions of Postoperative Ileus
Stephanie R Earnshaw, Teresa L Kauf, Cheryl McDade, et al.
Future Oncology (London, England)
|
April 7, 2022
Second-line treatments in advanced biliary tract cancer: systematic literature review of efficacy, effectiveness and safety
Zarmina S Khankhel, Sarah Goring, Sarah Bobiak, et al.
Molecular Genetics & Genomic Medicine
|
November 14, 2025
Living With Hypochondroplasia: A Qualitative Exploration of Children's and Caregivers' Experiences, Challenges, and Unmet Needs
Elisabeth M Oehrlein, Reni Pekala, Stacie Cavallaro, et al.
Cancer Medicine
|
October 20, 2022
Real-world outcomes among patients with advanced or metastatic biliary tract cancers initiating second-line treatment
David P Cosgrove, Emily S Reese, Nicole M Fulcher, et al.
Page
of 2